How much funding has NEUROP, INC. raised?

NEUROP, INC. has raised $155K in total funding, most recently a Grant round.

When was NEUROP, INC. founded?

NEUROP, INC. was founded in 2017.

Where is NEUROP, INC. headquartered?

NEUROP, INC. is headquartered in ATLANTA, Georgia, United States.

What industry is NEUROP, INC. in?

NEUROP, INC. operates in Biotech, Healthcare.

How many employees does NEUROP, INC. have?

NEUROP, INC. has 1-10 employees.

NEUROP, INC.

Q: Who are NEUROP, INC.'s investors?

NEUROP, INC.'s investors include National Institute of Neurological Disorders and Stroke (NINDS), SEED Capital.

ATLANTA, United States · Founded 2017 · $155K raised

Biotech

Healthcare

Headquarters: ATLANTA, Georgia
Employees: 1–10
Founded: 2017
Business Model: B2B

Website: neuropinc.com
Total Funding: $155K
Last Round: $155K GrantFeb 2014
Rounds: 2

About

NeurOp is a clinical-stage biotechnology company developing small-molecule medicines for central nervous system disorders by targeting the GluN2B subunit of neuronal NMDA receptors. Its lead candidate NP10679 is in Phase 1 clinical trials for severe perioperative pain and subarachnoid hemorrhage, with additional programs in stroke and treatment-resistant depression.

Summary

NEUROP, INC. is a Biotech company based in ATLANTA, United States, founded in 2017. It has raised $155K in total across 2 rounds, most recently a $155K Grant round in Feb 2014. Investors include National Institute of Neurological Disorders and Stroke (NINDS) and SEED Capital.